EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Short-Term Effects of Escalating Doses of Cholecalciferol on FGF23 and 24,25(OH)2 Vitamin D Levels: A Preliminary Investigation

Jessica Pepe, Luciano Colangelo iD, Roberta Pilotto, Viviana De Martino iD, Carla Ferrara iD, Alfredo Scillitani, Mirella Cilli, Salvatore Minisola iD, Ravinder Singh, Cristiana Cipriani iD

Nutrients · 2024

DOI: 10.3390/nu16213600 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Jessica Pepe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences (SCIAC), "Sapienza" University of Rome, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Cholecalciferol, Fibroblast Growth Factors, Vitamin D. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was partly funded by an unrestricted grant from Nycomed pharmaceutical company., an unrestricted grant from Nycomed pharmaceutical company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are few and controversial results on 24,25(OH)2D and FGF23 acute changes following supplementation with cholecalciferol.

Methods

Twenty-seven subjects with 25(OH)D < 30 ng/mL were randomized into three groups to receive a single oral dose of 25,000 I.U. or 600,000 I.U. of cholecalciferol or placebo, respectively. We measured 25(OH)D, 1,25(OH)2D, 24,25(OH)2D, and FGF23 levels at baseline and after 72 h. The 1,25(OH)2D/25(OH)D, 1,25(OH)2D/24,25(OH)2D, and 24,25(OH)2D/25(OH)D ratios were also calculated.

Results

There was an increase in 25(OH)D and 1,25 (OH)2D following both doses of cholecalciferol. In the group administered 600,000 I.U., there was a significant increase in the delta changes in 25(OH)D and 1,25(OH)2D compared to the placebo and in the delta 24,25(OH)D2 compared to the placebo and 25,000 I.U. groups (all p < 0.05). A decrease in both the 1,25(OH)2D/25(OH)D and 1,25(OH)2D/24,25(OH)2D ratio (all p < 0.05) was observed in the 600,000 I.U. group. FGF23 values significantly increased only in the group administered 600,000 I.U.

Conclusions

25(OH)D and 1,25(OH)D levels significantly increased following 600,000 IU cholecalciferol administration compared to 25,000 I.U. and placebo. Following the massive administration of cholecalciferol, the CYP24A1 enzyme is actively involved in catabolism, thus, avoiding toxic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth Factor-23CholecalciferolFibroblast Growth FactorsVitamin DHumansMaleFemaleAdultDietary SupplementsDose-Response Relationship, DrugYoung AdultVitamin D DeficiencyDouble-Blind MethodMiddle Aged

Stichwörter der Autor:innen

24,25(OH)2DFGF23cholecalciferolvitamin D

Substanzen

FGF23 protein, humanFibroblast Growth Factor-23CholecalciferolFibroblast Growth FactorsVitamin D25-hydroxyvitamin D24,25-dihydroxyvitamin D

Autor:innen und Institutionen

  • Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences (SCIAC), "Sapienza" University of Rome, 00161 Rome, Italy.
  • Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Unit of Endocrinology, Ospedale Casa Sollievo della Sofferenza, IRCCS, San Giovanni Rotondo, 71013 Foggia, Italy.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

ORCID-Profile: Luciano Colangelo, Viviana De Martino, Carla Ferrara, Salvatore Minisola, Cristiana Cipriani

Förderung

  • This study was partly funded by an unrestricted grant from Nycomed pharmaceutical company.
  • an unrestricted grant from Nycomed pharmaceutical company

Zitieren

APA

Pepe, J., Colangelo, L., Pilotto, R., De Martino, V., Ferrara, C., Scillitani, A., Cilli, M., Minisola, S., Singh, R., & Cipriani, C. (2024). Short-Term Effects of Escalating Doses of Cholecalciferol on FGF23 and 24,25(OH)2 Vitamin D Levels: A Preliminary Investigation. Nutrients. https://doi.org/10.3390/nu16213600

Vancouver

Pepe J, Colangelo L, Pilotto R, De Martino V, Ferrara C, Scillitani A, et al. Short-Term Effects of Escalating Doses of Cholecalciferol on FGF23 and 24,25(OH)2 Vitamin D Levels: A Preliminary Investigation. Nutrients. 2024. doi:10.3390/nu16213600

BibTeX
@article{Pepe2024,
  author = {Pepe, Jessica and Colangelo, Luciano and Pilotto, Roberta and De Martino, Viviana and Ferrara, Carla and Scillitani, Alfredo and Cilli, Mirella and Minisola, Salvatore and Singh, Ravinder and Cipriani, Cristiana},
  title = {Short-Term Effects of Escalating Doses of Cholecalciferol on FGF23 and 24,25(OH)2 Vitamin D Levels: A Preliminary Investigation},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16213600}
}
Kostenlos starten →